Cargando…
Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental setting
BACKGROUND: Rituximab has broad and increasing application in rheumatic diseases. It is known from lymphoma studies that natural killer (NK) cells can lyse rituximab-coated transformed B cells. However, the role of NK cells in mediating rituximab-induced depletion of non-malignant B cells is unknown...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024429/ https://www.ncbi.nlm.nih.gov/pubmed/27629249 http://dx.doi.org/10.1186/s13075-016-1101-3 |